Cadmus C. Rich, M.D.

Cadmus C. Rich, M.D.

Former Chief Medical OfficeratAura Biosciences· In proxies 2022–2023

Pay in FY2023+187% from the year before · Aura Biosciences stock -15.6% the same year

Cadmus C. Rich, M.D. was paid $1.7M in FY2023 (Dec), up 187%. Aura Biosciences stock fell 15.6% that year.

Pay$100 in the stock at the end of FY21 → $52
Pay is from the Summary Compensation Table of each Aura Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aura BiosciencesPublic company · 4 yr
    • Former Chief Medical Officer2022 – Present · 4 yrStock in role -64%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?